FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...

Lipocine expects trial data to support a 505(b)(2) new drug application submission for LPCN 1154 in 2026.

Psychosis is a rainbow of experiences involving changes in how we perceive the world. The most common alterations within psychosis are unshared sensory phenomena, like voices and visions, and unusual ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...

Mood disorders include depressive disorders and bipolar disorders. These types of psychiatric disorders affect a person’s emotions and may cause severe lows, called depression, and highs, called mania ...

Adjunctive omega-3 therapy failed to improve moderate-to-severe depression more than place ...

No statistically significant change in MADRS total score was observed with solriamfetol vs placebo in the overall study population. Topline results were announced from a phase 3 trial evaluating ...

Researchers from across China have discovered that schizophrenia (SCZ), bipolar disorder (BD) and major depressive disorder, ...

Moderate to severe pain after abdominal surgery is an independent risk factor for delirium and depressive symptoms among older adults.